Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026)

Beta Bionics has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $623000.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $623000.0, down 99.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 98.36% YoY), and the FY2025 annual result was $214.9 million, up 286.36% from the prior year.
• Cash from Financing Activities came in at $623000.0 for Q1 2026 at Beta Bionics, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $211.1 million in Q1 2025 to a low of -$1.2 million in Q3 2024.
• The 3-year median for Cash from Financing Activities is $623000.0 (2026), against an average of $30.1 million.
• Across the five-year window, Cash from Financing Activities soared 3518550.0% in 2025 and plunged 99.7% in 2026, its largest moves.
• Beta Bionics' Cash from Financing Activities stood at $56.9 million in 2024, then plunged by 98.14% to $1.1 million in 2025, then sank by 41.23% to $623000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $623000.0 (Q1 2026), $1.1 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.